February 17, 2009
Tests Show Success in Rapid, Accurate Discovery of New Drug Possibilities ST. LOUIS, Mo.--Tripos™, a leading provider of drug discovery informatics products and services, today announced an agreement with the European Molecular Biology Laboratory (EMBL), Europe’s leading research institution for molecular biology, to license Tripos’ Themis™ and Surflex-Dock™ software to support their efforts in Chemical [...]
February 17, 2009
Guildford, UK, February 17 2009 – Global informatics provider IDBS today announced that the Immunovirology Division of the French Atomic Energy Agency (Commissariat à l’Ènergie Atomique, CEA) has selected E-WorkBook for Biology (BioBook) to capture, collate, analyse and share experimental data across its multi-user immunovirology research projects. Managed by Roger Le Grand, CEA’s Immunovirology Division [...]
February 17, 2009
ST. JOSEPH, Mich., Feb. 17 -- GeneGo, Inc., the leading systems biology tools company, announced today that Millipore has licensed 250 manually curated pathway maps from GeneGo, Inc. for their new Interactive Biological Pathway Tool. Available at www.millipore.com/pathways, the tool links Millipore's cutting edge antibodies, proteins, and assays as well as relevant bioinformatics content to [...]
Qualitest Presents The RPA 8000, Rubber Process Analyzer
February 17, 2009
Qualitest presents the RPA 8000 Rubber Process Analyzer. The RPA 8000 allows rubber to be tested under conditions of variable strain frequency and temperature which reveal important differences in rheological, rheometric and dynamic viscoelastic properties. (1888PressRelease) February 17, 2009 - The RPA 8000 is an advanced dynamic mechanical rheological test instrument designed to measure the [...]
TechniKrom’s Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
February 17, 2009
GLENVIEW, Ill., Feb. 17 -- TechniKrom, Inc. and Asahi Kasei Medical Co., Ltd., who have a longstanding partnership in the commercialization of equipment for use with Planova(TM) virus removal filters, have reached agreement for the transfer of TechniKrom's biopharmaceutical business to Asahi Kasei Medical's full ownership. The integration of operations will be marked by the [...]
February 17, 2009
A research study published online this week in the Journal of Infectious Disease reports that HIV resistance mutations present in as little as 1% of the viral population have a significant impact on clinical outcomes. The paper outlines the results of a collaborative study between 454 Life Sciences, a Roche company, and a Yale School [...]
Xenomics Offers New Gender Prediction Test to Expectant Mothers
February 17, 2009
MONMOUTH JUNCTION, N.J.--Xenomics, Inc. (PINKSHEETS: XNOM), a developer of non-invasive next-generation molecular diagnostics, announced today that it will begin offering a gender prediction test as a service to expectant mothers who are interested in learning the gender of their baby as early as the 7th week of their pregnancy, much earlier than the availability of [...]
Ahura Scientific, Inc. Names Industry Veteran Michael Falvey Vice President, CFO
February 17, 2009
WILMINGTON, MA Ahura Scientific, Inc., a leader in rugged, ultra-compact handheld instruments for chemical identification, announced today that it has hired Michael Falvey as Vice President and Chief Financial Officer. Falvey was selected by Ahura Scientific for his more than 25 years of experience managing the finance, accounting, administration, human resource and IT functions at [...]
Phenomenex Adds Another Unique Selectivity to Lux Chiral Column Line
February 17, 2009
Torrance, CA (February 17, 2009) - Phenomenex Inc., a global leader in the manufacture of separation science consumables, introduces the Lux Amylose-2 chiral column, adding unique new selectivity to its HPLC solutions for the identification and resolution of enantiomers. The new column chemistry incorporates an amylose backbone with a novel 5-chloro-2-methylphenylcarbamate derivative to give chiral [...]
February 17, 2009
Technology enhances biological activity (regenerative potential) of stem cells and accelerates development of proprietary enhanced therapeutics GAITHERSBURG, Md., Feb. 17 -- MaxCyte announces today the introduction of its GT(TM) Flow Transfection System at the 4th Annual Stem Cell Summit to be held in New York, NY. The MaxCyte GT(TM) Flow Transfection System is a validated, [...]
